The last several years have yielded results from several large randomized controlled trials that evaluated the efficacy and safety of chemoprophylaxis for prevention of HIV-1 acquisition. These trials have evaluated administration of tenofovir-based antiretroviral preparations either orally or vaginally, and informed the U.S. FDA’s approval of tenofovir-emtricitabine for HIV-1 pre-exposure...